rs782255281
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000260.4(MYO7A):c.2115C>A(p.Cys705*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000274 in 1,460,970 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000260.4 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYO7A | NM_000260.4 | c.2115C>A | p.Cys705* | stop_gained | 18/49 | ENST00000409709.9 | NP_000251.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYO7A | ENST00000409709.9 | c.2115C>A | p.Cys705* | stop_gained | 18/49 | 1 | NM_000260.4 | ENSP00000386331.3 | ||
MYO7A | ENST00000458637.6 | c.2115C>A | p.Cys705* | stop_gained | 18/49 | 1 | ENSP00000392185.2 | |||
MYO7A | ENST00000409619.6 | c.2082C>A | p.Cys694* | stop_gained | 19/50 | 1 | ENSP00000386635.2 | |||
MYO7A | ENST00000670577.1 | n.-46C>A | upstream_gene_variant | ENSP00000499323.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.0000121 AC: 3AN: 248848Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135094
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1460970Hom.: 0 Cov.: 31 AF XY: 0.00000275 AC XY: 2AN XY: 726758
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Autosomal recessive nonsyndromic hearing loss 2 Pathogenic:1
Pathogenic, no assertion criteria provided | case-control | Genetic Testing Center for Deafness, Department of Otolaryngology Head & Neck Surgery, Institute of Otolaryngology, Chinese PLA General Hospital | Feb 26, 2019 | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 26, 2023 | This sequence change creates a premature translational stop signal (p.Cys705*) in the MYO7A gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MYO7A are known to be pathogenic (PMID: 8900236, 25404053). This variant is present in population databases (rs782255281, gnomAD 0.01%). This premature translational stop signal has been observed in individual(s) with Usher syndrome (PMID: 24618850, 33691693). ClinVar contains an entry for this variant (Variation ID: 228377). For these reasons, this variant has been classified as Pathogenic. - |
Rare genetic deafness Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jun 10, 2015 | The p.Cys705X variant in MYO7A has been reported as a homozygous variant in one individual with Usher syndrome type 1 (Yoshimura 2014). It has also been identif ied in 2/8608 East Asian chromosomes by the Exome Aggregation Consortium (http:/ /exac.broadinstitute.org). Although this variant has been seen in the general po pulation, its frequency is low enough to be consistent with a recessive carrier frequency. This nonsense variant creates a premature termination codon at positi on 705 and is predicted to lead to a truncated or absent protein. In summary, th is variant meets our criteria to be classified as pathogenic for Usher syndrome (www.partners.org/personalizedmedicine/lmm). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at